Skip to main content
. 2012 Jan 31;106(5):955–961. doi: 10.1038/bjc.2012.15

Figure 2.

Figure 2

Peak intensity data at baseline for (A) oesophageal cancer patients vs case controls and (B) according to survival. Sample group statistics (mean and s.d.) obtained for (A) plasma peaks (m/z) differing significantly (P<0.05, appropriate parametric or non-parametric test) between case controls (normal, n=36) and oesophageal cancer (tumour, n=21) patients at baseline or (B) according to survival from date of diagnosis, between the greater than 11 months group (good, n=5) and the <7 months group (poor, n=5).